On the stock market since 2012, it operates in the world of health and science. It has 2,026 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 8% a year over the last 4 years. Red columns mark years that ended in a loss.
The two sides balance each other out — the picture is neither a safety net nor an alarm.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 3 years, sales grew about 9% a year on average.
It pays out $0.22 per share each year — regular cash for whoever holds the stock.
The company’s market value is 72 times its annual profit. Even a small disappointment could hit the price hard.
On our five-subject report card, LBTSF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: LBTSF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.